“These autism/neurodevelopmental disorder patents make claim for NNZ-2591 producing an improvement in one or more of a wide range of symptoms, including many of those being assessed in the current Phase 2 trials.”
Truly great post; I’ll guarantee that 90% of holders here or the stock in general didn’t realize the above, thanks again Hottod for all your research.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$15.39 |
Change
-0.360(2.29%) |
Mkt cap ! $1.938B | |||
| Open | High | Low | Value | Volume |
| $15.80 | $15.80 | $15.19 | $6.795M | 439.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2167 | $15.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.45 | 1494 | 2 |
View Market Depth
| Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |